This page describes a colorimetric sandwich ELISA kit for CSF2 measurement, labeled as an "Antibody ELISA Kit." Operationally, you should treat it as an ELISA-based detection workflow where antibodies are the capture/detection reagents enabling CSF2 quantification. If your goal is to evaluate anti-CSF2 antibodies (e.g., ADA), please tell us-those assays require different formats and controls than cytokine quantification.
Yes, that's a common application. We recommend collecting supernatants at consistent timepoints, clarifying samples to remove debris, and running technical replicates. Include a common pooled QC sample across plates to compare M1/M2 conditions reliably over multiple runs. If you're mapping kinetics, a short time-course pilot can help choose a window where CSF2 differences are most separable.
Heterophilic antibodies and rheumatoid factor can cause non-specific bridging in immunoassays. To mitigate, dilute samples, use appropriate blocking strategies, and include matrix-matched controls where feasible. If you suspect interference, compare results with and without heterophilic blocking reagents and look for non-linear dilution behavior. We can help design an interference check so your reported CSF2 signal is trustworthy.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.